Short-Read Sequencing - Global Strategic Business Report 2026

The global market for Short-Read Sequencing was valued at US$11.8 Billion in 2025 and is projected to reach US$24.7 Billion by 2032, growing at a CAGR of 11.2% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Short-Read Sequencing Market - Key Trends and Drivers Summarized

How Is Short-Read Sequencing Transforming Genomics?

Short-read sequencing is a next-generation sequencing (NGS) technology that reads short fragments of DNA, typically between 100 and 300 base pairs. It is widely used in genomics for applications such as whole-genome sequencing, targeted sequencing, and RNA sequencing. Renowned for its high accuracy, scalability, and cost-effectiveness, short-read sequencing plays a critical role in research areas like cancer genomics, personalized medicine, and microbiome studies. As advancements in bioinformatics enhance data analysis capabilities, short-read sequencing continues to be a powerful tool for understanding genetic variation, disease mechanisms, and population genetics.

What Are the Key Segments in the Short-Read Sequencing Market?

Key technologies include Illumina sequencing and Ion Torrent sequencing, with Illumina sequencing holding a major share due to its high accuracy, extensive throughput, and broad application range. Applications span across oncology, infectious disease research, genetic testing, and agricultural genomics, with oncology accounting for a significant market share as cancer research and diagnostics rely heavily on DNA sequencing for precision medicine. End-users include research institutions, clinical laboratories, pharmaceutical companies, and academic centers, with research institutions leading the market due to their focus on genomics studies and disease research.

How Is Short-Read Sequencing Being Used Across Research and Clinical Applications?

In oncology, short-read sequencing is used for detecting somatic mutations, copy number variations, and gene fusions, facilitating personalized cancer treatment strategies. Infectious disease research leverages short-read sequencing to identify pathogens, track outbreaks, and study antimicrobial resistance, supporting public health initiatives. Genetic testing applications utilize short-read sequencing to identify genetic disorders, aiding in diagnostics and reproductive health management. In agriculture, short-read sequencing is applied in crop genomics and breeding programs to improve yield, resistance, and nutritional value. Additionally, the integration of bioinformatics and cloud computing has enhanced the analysis of large-scale sequencing data, enabling more accurate and faster genomic insights.

What Factors Are Driving the Growth in the Short-Read Sequencing Market?

The growth in the Short-Read Sequencing market is driven by several factors, including the increasing demand for genomic research in fields like oncology, infectious diseases, and personalized medicine. The growing focus on precision medicine, which relies heavily on genetic insights for tailored treatment, has accelerated the adoption of short-read sequencing in clinical settings. Advancements in sequencing technology, such as higher throughput and reduced costs, have made sequencing more accessible to a broader range of applications. The expanding use of bioinformatics tools and cloud-based data analysis has improved the efficiency of sequencing workflows, supporting broader adoption. Additionally, government funding for genomics research and the development of new diagnostic solutions have contributed to the growth of the short-read sequencing market.

Report Scope

The report analyzes the Short-Read Sequencing market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Technology (Next-Generation Sequencing, Sanger Sequencing); Product (Consumables, Instruments, Services); End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Next-Generation Sequencing segment, which is expected to reach US$16.4 Billion by 2032 with a CAGR of a 10.8%. The Sanger Sequencing segment is also set to grow at 11.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $3.4 Billion in 2025, and China, forecasted to grow at an impressive 10.4% CAGR to reach $4.3 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Short-Read Sequencing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Short-Read Sequencing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Short-Read Sequencing Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as BGI Genomics Co Ltd., CD Genomics, Element Biosciences, Illumina, Inc., Integra Biosciences AG and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Short-Read Sequencing market report include:

• BGI Genomics Co Ltd.
• CD Genomics
• Element Biosciences
• Illumina, Inc.
• Integra Biosciences AG
• MedGenome, Inc.
• Oxford Nanopore Technologies, Ltd.
• Pacific Biosciences of California, Inc.
• seqWell
• Thermo Fisher Scientific, Inc.

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.